Back

A new paradigm for Prelamin A proteolytic processing by ZMPSTE24: the upstream SY^LL cleavage occurs first and there is no CaaX processing by ZMPSTE24

Nie, L.; Spear, E.; Babatz, T. D.; Quigley, A.; Dong, Y. Y.; Chu, A.; Rotty, B.; Chalk, R.; Mukhopadhyay, S. M. M.; Burgess-Brown, N. A.; Pike, A. C. W.; Young, S. G.; Michaelis, S.; Carpenter, E. P.

2020-05-13 biochemistry
10.1101/2020.05.13.093849 bioRxiv
Show abstract

Human ZMPSTE24, an integral membrane zinc metalloprotease, is required for conversion of prelamin A to mature lamin A, a component of the nuclear lamina and failure of this processing causes premature ageing disorders. ZMPSTE24 has also been implicated in both type 2 diabetes mellitus and in viral-host response mechanisms, but to date its only confirmed substrate is the precursor for lamin A. Prelamin A is thought to undergo four C-terminal post-translational modifications in the following order: farnesylation, SIM tripeptide cleavage, carboxymethylation and upstream "SY^LL" cleavage. Here we present evidence that the sequence of events does not follow the accepted dogma. We assessed cleavage of long human prelamin A sequence peptides by purified human ZMPSTE24 combined with FRET and mass spectrometry to detect products. Surprisingly, we found that the "SY^LL" cleavage occurs before and independent of the C-terminal CSIM modifications. We also found that ZMPSTE24 does not perform the predicted C^SIM tripeptide cleavage, but rather it removes an IM dipeptide. ZMPSTE24 can perform a tripeptide cleavage with a canonical CaaX box (C: cysteine; a: aliphatic; X: any residue), but the C-terminus of prelamin A is not a true CaaX sequence. Regardless of the C-terminal modifications of prelamin A, ZMPSTE24 can perform upstream SY^LL cleavage, thus removing the unwanted farnesylated C-terminus. Therefore, it is failure of SY^LL cleavage, not the C-terminal processing that is the likely cause of progeroid disorders.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 2%
14.8%
2
Nature Communications
4913 papers in training set
Top 16%
10.5%
3
The EMBO Journal
267 papers in training set
Top 0.1%
6.9%
4
Life Science Alliance
263 papers in training set
Top 0.1%
6.4%
5
Journal of Biological Chemistry
641 papers in training set
Top 0.3%
4.9%
6
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 16%
4.4%
7
Open Biology
95 papers in training set
Top 0.1%
4.0%
50% of probability mass above
8
EMBO reports
136 papers in training set
Top 1%
3.1%
9
Molecular Cell
308 papers in training set
Top 5%
2.9%
10
PLOS Biology
408 papers in training set
Top 5%
2.8%
11
EMBO Reports
88 papers in training set
Top 0.1%
2.5%
12
Cell Reports
1338 papers in training set
Top 20%
2.1%
13
iScience
1063 papers in training set
Top 10%
2.1%
14
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.1%
1.9%
15
Journal of Cell Biology
333 papers in training set
Top 2%
1.7%
16
PLOS Genetics
756 papers in training set
Top 8%
1.7%
17
Scientific Reports
3102 papers in training set
Top 59%
1.7%
18
PLOS Pathogens
721 papers in training set
Top 6%
1.5%
19
Structure
175 papers in training set
Top 2%
1.3%
20
PLOS ONE
4510 papers in training set
Top 60%
1.2%
21
The FEBS Journal
78 papers in training set
Top 0.6%
0.9%
22
Aging Cell
144 papers in training set
Top 3%
0.9%
23
Science Advances
1098 papers in training set
Top 26%
0.9%
24
Journal of Investigative Dermatology
42 papers in training set
Top 0.4%
0.9%
25
Cell Death Discovery
51 papers in training set
Top 1%
0.8%
26
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.8%
27
Journal of Molecular Biology
217 papers in training set
Top 3%
0.8%
28
Human Mutation
29 papers in training set
Top 0.7%
0.8%
29
Nucleic Acids Research
1128 papers in training set
Top 18%
0.7%
30
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 10%
0.7%